Today: 20 May 2026
3M stock price drops after outlook miss, with tariffs and 2026 demand back in focus
21 January 2026
2 mins read

3M stock price drops after outlook miss, with tariffs and 2026 demand back in focus

NEW YORK, Jan 20, 2026, 7:19 PM EST — After-hours

  • 3M shares dropped roughly 7% in after-hours trading following a 2026 profit forecast that came in slightly under expectations.
  • Management noted patchy demand and new tariff worries, despite better margins and a quarterly earnings beat.
  • Investors are eyeing consumer-related divisions and looking for any updates on tariff schedules before Feb. 1.

Shares of 3M (MMM) dropped roughly 7% to about $156 in after-hours trading Tuesday, as the industrial giant’s profit forecast for 2026 fell just short of Wall Street’s estimates. This weighed on sentiment despite a modest beat in fourth-quarter results.

This reaction is crucial as 3M aims to persuade investors that cost reductions and product adjustments will sustain earnings growth despite uneven end-demand. Even a slight miss in guidance, by just a penny, reignites questions about how much of the margin improvement is truly “repeatable” versus driven by easy comparisons.

U.S. stocks tumbled sharply Tuesday amid jitters over fresh tariff threats linked to Greenland, sending shockwaves through industrial supply chains and pricing.

3M reported adjusted earnings of $1.83 per share for the fourth quarter, beating forecasts of $1.80. Adjusted revenue came in at $6.02 billion, slightly surpassing estimates. However, sales in its consumer segment dropped 1.2% year-over-year, reflecting softer retail demand.

In the earnings release, Chief Executive William Brown said 2025 “reshap[ed] our operating model” and claimed that “innovation and commercial execution” position the company to outperform once more in 2026. Source

3M projected adjusted earnings for 2026 in the range of $8.50 to $8.70 per share, with the midpoint just a cent shy of the $8.61 analyst consensus, based on LSEG data. The company aims to reach an operating margin of 25% by the close of 2027; this margin measures operating profit relative to sales.

During the earnings call, Brown noted that the “existing 20 cents impact” from tariffs is already factored into the 2026 forecast range. He also warned that if President Donald Trump follows through on his latest tariff threats targeting parts of Europe, 3M could face a $30 million to $40 million hit this year.

Near-term challenges look unexciting: roofing granules and some segments of the auto aftermarket should remain weak early next year, Brown noted. CFO Anurag Maheshwari sought to calm investors, saying he anticipates “the macro in 2026 to be a little bit better.”

A recent filing revealed 3M submitted its earnings and 2026 outlook in a Form 8-K, including the earnings release. The quarter’s results factored in “special items” like litigation expenses and PFAS-related charges, underscoring how legacy issues continue to impact reported profits. Source

That said, the downside risks are clear. Should tariff threats materialize into actual orders, or if U.S. consumers continue to pull back, 3M could face a tough choice: protect volumes by cutting prices or safeguard margins through stricter cost controls.

On Wednesday, traders will be eyeing if the stock can stabilize following the widespread selloff — and if tariff news continues to overshadow earnings in driving the tape.

The next key date is Feb. 1, when Trump has indicated new tariffs could hit goods from several European countries, followed by a potential increase on June 1. This schedule is now baked into 3M’s 2026 forecasts, and investors will be watching closely to see how solid that timing really is.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Previous Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

Chevron stock price slips as Tengiz shutdown headlines hit CVX; Turkey talks add fresh focus
Next Story

Chevron stock price slips as Tengiz shutdown headlines hit CVX; Turkey talks add fresh focus

Go toTop